- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Jiangsu ShengDiYa Medicine Co., Ltd.
Total 1358 results
-
Jiangsu ShengDiYa Medicine Co., Ltd.Dongguan People's HospitalUnknownNonsquamous Nonsmall Cell Neoplasm of Lung
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdult Patients With Chronic Primary ITP | Adult Patients With SAA Who do Not Respond Well to Immunosuppressive TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent Ovarian CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingSedation in Non-intubated Diagnostic and Therapeutic ProceduresChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingGout With Hyperuricemia in Adults
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRelapsed/Refractory PTCLT With at Least One Line of Prior Systemic TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Prostate Cancer
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingInfertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early OvulationChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Gastroenteropancreatic Neuroendocrine TumorChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingImmune Thrombocytopenia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingCastration-Resistant Prostate CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAutoimmune HepatitisChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Esophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and TaxaneChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory Non-Hodgkin's Lymphoma and Multiple MyelomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout With Hyperuricemia in Adults
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-radiographic Axial SpondyloarthritisChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Malignant Tumor
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingImproved Glycemic Control in Patients With Type 2 Diabetes
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingNasopharyngeal CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment-naive Severe Aplastic AnemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory B-cell Non-Hodgkin's LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingImmune ThrombocytopeniaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHepatic Impairment | Healthy ParticipantsChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRenal Cell Carcinoma | Cervical Cancer | Endometrial Cancer | Urothelial Carcinoma | Ovarian Cancer RecurrentChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGastric Cancer | GastroEsophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGraft-versus-host DiseaseChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAsthma With Eosinophilic PhenotypeChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHormone Sensitive Prostate CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSecond-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorChina